GEO Investing

Summary Cannabidiol (“CBD”), a cannabis-based substance, is the focus of INSY and GWPH, two companies competing to develop CBD for the treatment of Dravet Syndrome, a form of childhood epilepsy. Contrary to what appears to be respected analysts’ expectations, INSY […]

Call(s) to Action: WSTI ($0.73) – Yesterday we covered our short position, locking in gains to take advantage of other opportunities.  Will continue to watch closely and may look to re-enter a short position. EXETF ($6.76) – In its Q2 […]

Call(s) to Action: MAG ($25.00) –  Reported strong Q2 2014 results; Reported non-GAAP EPS of $0.74 more than doubling prior year results of $0.36 and crushing analyst EPS estimates of $0.32. Ex-GEO portfolio position reported significant increase in EPS due […]

Call(s) to Action: QLTY ($13.28) – Will nibble at shares prior to Q2 2014 earnings which are expected to be announced tomorrow after the close. It appears that at the start of Q3 2014 company will experience a GPR of 6. Overall 2015 […]